AstraZeneca starts mid-stage TB drug trial in South Africa
LONDON (Reuters) - A new experimental drug that may fight drug-resistant strains of the lung disease tuberculosis is being tested in South Africa, where the first patient has been enrolled into a mid-stage clinical trial. (Source: Reuters: Health)
No comments:
Post a Comment